Effects of exercise on glucagon-like peptide-1 (GLP-1)

Appetite and eating behaviour are controlled by a variety of peripheral signals that change in response to food intake and act in the hypothalamus and brainstem. Glucagon-like peptide-1 (GLP-1) is a brain-gut peptide that has a variety of physiological functions and is involved in appetite regulation. Abnormalities in the expression and secretion of GLP-1 have been shown to occur in obesity, diabetes, and hyperlipidemia, and improving these abnormalities has become an important challenge. Exercise has recently been shown to have an influence on GLP-1 concentrations. This short review aims to highlight the association between exercise and the blood kinetics of GLP-1 and discuss the relevance of GLP-1 in the regulation of appetite to prevent obesity.

[1]  M. Gassmann,et al.  Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells , 2011, Nature Medicine.

[2]  J. Holst,et al.  Obesity – an indication for GLP‐1 treatment? Obesity pathophysiology and GLP‐1 treatment potential , 2011, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[3]  R. Seeley,et al.  GLP-1 and energy balance: an integrated model of short-term and long-term control , 2011, Nature Reviews Endocrinology.

[4]  J. Holst,et al.  The effects of exercise-induced weight loss on appetite-related peptides and motivation to eat. , 2010, The Journal of clinical endocrinology and metabolism.

[5]  T. Yoshikawa,et al.  Comparable effects of moderate intensity exercise on changes in anorectic gut hormone levels and energy intake to high intensity exercise. , 2009, The Journal of endocrinology.

[6]  T. Yoshikawa,et al.  Changes in gut hormone levels and negative energy balance during aerobic exercise in obese young males. , 2009, The Journal of endocrinology.

[7]  S. Barr,et al.  GLP‐1 and Appetite Responses to a Meal in Lean and Overweight Adolescents Following Exercise , 2008, Obesity.

[8]  J. Holst.  The physiology of glucagon-like peptide 1. , 2007, Physiological reviews.

[9]  P. Hellström,et al.  Appetite signaling: From gut peptides and enteric nerves to brain , 2007, Physiology & Behavior.

[10]  S. Bloom,et al.  Effects of exercise on gut peptides, energy intake and appetite. , 2007, The Journal of endocrinology.

[11]  S. Bloom,et al.  Gut hormones and appetite control. , 2007, Gastroenterology.

[12]  J. Pinkney,et al.  Gut peptides and the regulation of appetite , 2006, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[13]  J. Ingwall,et al.  Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  D. Drucker,et al.  A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis. , 2004, Diabetes.

[15]  P. Hellström,et al.  Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects , 2004, British Journal of Nutrition.

[16]  A. Astrup,et al.  A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[17]  J. Holst,et al.  GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[18]  J. Habener,et al.  Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. , 1996, Endocrinology.

[19]  V. Marks,et al.  Attenuated GLP-1 secretion in obesity: cause or consequence? , 1996, Gut.

[20]  D. Smith,et al.  A role for glucagon-like peptide-1 in the central regulation of feeding , 1996, Nature.

[21]  B. Gallwitz.  Anorexigenic effects of GLP-1 and its analogues. , 2012, Handbook of experimental pharmacology.

[22]  T. Rink,et al.  Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake. , 1996, Metabolism: clinical and experimental.